Rumen T.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Therapeutic Equivalence of CHF5993 Combination Therapy Using HFA-152a Versus HFA-134a in Adults With Mild to Moderate Asthma
- Phase 3 Study of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma
- Noninferiority of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide versus beclometasone dipropionate/formoterol fumarate in asthma
Data & Insights
Has run more than one trial at 368 of 788 partner sites.
Specializations
Respiratory Disease Management
The investigator specializes in treating severe respiratory conditions, with particular emphasis on innovative therapeutic approaches for both asthma and chronic obstructive pulmonary disease (COPD).
- Advanced Asthma Therapies
- COPD Treatment Optimization
- Bronchiectasis Management
Focus areas include triple therapy combinations and novel therapeutic agents for respiratory disease control.
Infectious Disease Treatment
The investigator conducts research in treating various viral respiratory infections, including specialized therapeutic approaches for acute and chronic conditions.
- COVID-19 Treatment
- Influenza Management
- Respiratory Syncytial Virus (RSV) Therapy
Expertise extends to antiviral treatments and vaccine efficacy studies for respiratory infections.
Sleep Medicine
The investigator explores therapeutic solutions for sleep disorders, with a particular focus on treating insomnia across different age groups.
- Pediatric Sleep Disorders
- Adolescent Insomnia Treatment
- Sleep Medicine Innovation
Research includes novel pharmaceutical interventions for sleep regulation and disorder management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.